Nanoveu Limited
NNVUF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $1 |
| % Growth | -90.2% | -35.7% | -80.8% | – |
| Cost of Goods Sold | -$0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 153.2% | 24.6% | 17.1% | 43% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2 | $1 | $2 | $2 |
| SG&A Expenses | $2 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1 | -$0 | -$0 | -$0 |
| Operating Expenses | $3 | $1 | $1 | $2 |
| Operating Income | -$3 | -$1 | -$2 | -$1 |
| % Margin | -40,972.1% | -2,092.2% | -1,564.6% | -259% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$3 | -$1 | -$2 | -$2 |
| Tax Expense | $0 | $0 | -$0 | $0 |
| Net Income | -$3 | -$2 | -$2 | -$2 |
| % Margin | -40,880.4% | -3,090.6% | -1,675.8% | -297.1% |
| EPS | -0.004 | -0.006 | -0.008 | -0.01 |
| % Growth | 36.2% | 26.6% | 18.6% | – |
| EPS Diluted | -0.004 | -0.006 | -0.008 | -0.01 |
| Weighted Avg Shares Out | 442 | 375 | 230 | 174 |
| Weighted Avg Shares Out Dil | 442 | 375 | 230 | 174 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | -$1 | -$2 | -$1 |
| % Margin | -24,602.2% | -1,925.5% | -1,507.2% | -252.6% |